Dhriti Mukhopadhyay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dhriti Mukhopadhyay has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Himakarnika Alluri
2 shared publicationsKatie C. Wiggins-Dohlvik
Texas A&M University/Scott and White Hospital, Temple, TX, USA
2 shared publicationsLena Perger
Department of Surgery, Scott & White Healthcare and Texas A&M Health Science Center College of Medicine, Temple, Tex
2 shared publicationsMadhava Beeram
A Texas A&M College of Medicine , Temple , TX , USA
2 shared publicationsMatthew L. Davis
Texas A&M University/Scott and White Hospital, Temple, TX, USA
2 shared publicationsR. John Solaro
From the Department of Medical Physiology (P.C.R., Y.L., M.I.A., B.M.M., C.W.T.) and Division of Molecular Cardiology, Department of Medicine (C.M.T., R.K., K.M.B.), Texas A&M University Health Science Center, College of Medicine, Temple City; Internal Medicine/Division of Cardiology (D.T.K., C.W.T.) and Department of Surgery (G.F.D., D.M.), Baylor Scott & White Health-Central Texas, Temple City; Department of Cell and Regenerative Biology and Biotechnology Center, University of Wisconsin...
2 shared publications
Latest Publications
- 1 January 2018
- Published by Elsevier in The American Journal of Surgery
- Vol. 215 (1) , 28-36
Implementation of a standardized handoff protocol for post-operative admissions to the surgical intensive care unit
- 1 January 2018
- Published by Elsevier in The American Journal of Surgery
- Vol. 215 (1) , 28-36
Implementation of a standardized handoff protocol for post-operative admissions to the surgical intensive care unit
- 1 June 2016
- Published by Elsevier in The American Journal of Surgery
- Vol. 211 (6) , 1095-1098
Enhancing surgical safety using digital multimedia technology
- 1 June 2016
- Published by Elsevier in The American Journal of Surgery
- Vol. 211 (6) , 1095-1098
Enhancing surgical safety using digital multimedia technology
- 28 August 2015
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 29 (13) , 2098-2103
Maternal pre-eclampsia as a risk factor for necrotizing enterocolitis
Objective: Similar pro-inflammatory responses are present in pre-eclampsia (PE) and necrotizing enterocolitis (NEC). We hypothesized that maternal PE is an independent risk factor for the development of NEC. Methods: A retrospective database of all live births (2008–2011) at a tertiary center was constructed. Infant and maternal characteristics were gathered. Babies born to mothers with or without PE were compared. Data were analyzed using Mann–Whitney U, Pearson's χ2, binary logistic regression and relative risks. Results: Incidence of NEC was 1.5% in non-PE and 4.6% in the PE group (p < 0.001), but once controlled for gestational age and birth weight, the difference lost statistical significance. PE babies were more frequently preterm (41.4% versus 14.5%, p < 0.001) and had intrauterine growth restriction (IUGR) (10.2% versus 6.3%, p < 0.001). Within preterm babies, 9.0% of non-PE and 10.8% of PE babies developed NEC (p = 0.25). Effect of PE was significant in sub-group of IUGR babies, with NEC in 1.5% of non-PE and 13.6% in PE babies (p < 0.001). Conclusions: Maternal PE is an independent risk factor for the development of NEC in some sub-groups of babies, most notably with IUGR. Fetal hypoxia caused by abnormal placentation in PE leads to restricted growth, and may be the underlying mechanism that predisposes the newborn to NEC.
- 28 August 2015
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 29 (13) , 2098-2103
Maternal pre-eclampsia as a risk factor for necrotizing enterocolitis
Objective: Similar pro-inflammatory responses are present in pre-eclampsia (PE) and necrotizing enterocolitis (NEC). We hypothesized that maternal PE is an independent risk factor for the development of NEC. Methods: A retrospective database of all live births (2008–2011) at a tertiary center was constructed. Infant and maternal characteristics were gathered. Babies born to mothers with or without PE were compared. Data were analyzed using Mann–Whitney U, Pearson's χ2, binary logistic regression and relative risks. Results: Incidence of NEC was 1.5% in non-PE and 4.6% in the PE group (p < 0.001), but once controlled for gestational age and birth weight, the difference lost statistical significance. PE babies were more frequently preterm (41.4% versus 14.5%, p < 0.001) and had intrauterine growth restriction (IUGR) (10.2% versus 6.3%, p < 0.001). Within preterm babies, 9.0% of non-PE and 10.8% of PE babies developed NEC (p = 0.25). Effect of PE was significant in sub-group of IUGR babies, with NEC in 1.5% of non-PE and 13.6% in PE babies (p < 0.001). Conclusions: Maternal PE is an independent risk factor for the development of NEC in some sub-groups of babies, most notably with IUGR. Fetal hypoxia caused by abnormal placentation in PE leads to restricted growth, and may be the underlying mechanism that predisposes the newborn to NEC.
- 1 May 2015
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 8 (3) , 582-594
Phosphorylation of Cardiac Myosin-Binding Protein-C Is a Critical Mediator of Diastolic Function
Background—: Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for ≈50% of all cases of HF and currently has no effective treatment. Diastolic dysfunction underlies HFpEF; therefore, elucidation of the mechanisms that mediate relaxation can provide new potential targets for treatment. Cardiac myosin-binding protein-C (cMyBP-C) is a thick filament protein that modulates cross-bridge cycling rates via alterations in its phosphorylation status. Thus, we hypothesize that phosphorylated cMyBP-C accelerates the rate of cross-bridge detachment, thereby enhancing relaxation to mediate diastolic function. Methods and Results—: We compared mouse models expressing phosphorylation-deficient cMyBP-C(S273A/S282A/S302A)–cMyBP-C(t3SA), phosphomimetic cMyBP-C(S273D/S282D/S302D)–cMyBP-C(t3SD), and wild-type-control cMyBP-C(tWT) to elucidate the functional effects of cMyBP-C phosphorylation. Decreased voluntary running distances, increased lung/body weight ratios, and increased brain natriuretic peptide levels in cMyBP-C(t3SA) mice demonstrate that phosphorylation deficiency is associated with signs of HF. Echocardiography (ejection fraction and myocardial relaxation velocity) and pressure/volume measurements (−d P /d t min , pressure decay time constant τ -Glantz, and passive filling stiffness) show that cMyBP-C phosphorylation enhances myocardial relaxation in cMyBP-C(t3SD) mice, whereas deficient cMyBP-C phosphorylation causes diastolic dysfunction with HFpEF in cMyBP-C(t3SA) mice. Simultaneous force and [Ca 2+ ] i measurements on intact papillary muscles show that enhancement of relaxation in cMyBP-C(t3SD) mice and impairment of relaxation in cMyBP-C(t3SA) mice are not because of altered [Ca 2+ ] i handling, implicating that altered cross-bridge detachment rates mediate these changes in relaxation rates. Conclusions—: cMyBP-C phosphorylation enhances relaxation, whereas deficient phosphorylation causes diastolic dysfunction and phenotypes resembling HFpEF. Thus, cMyBP-C is a potential target for treatment of HFpEF.
- 1 May 2015
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 8 (3) , 582-594
Phosphorylation of Cardiac Myosin-Binding Protein-C Is a Critical Mediator of Diastolic Function
Background—: Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for ≈50% of all cases of HF and currently has no effective treatment. Diastolic dysfunction underlies HFpEF; therefore, elucidation of the mechanisms that mediate relaxation can provide new potential targets for treatment. Cardiac myosin-binding protein-C (cMyBP-C) is a thick filament protein that modulates cross-bridge cycling rates via alterations in its phosphorylation status. Thus, we hypothesize that phosphorylated cMyBP-C accelerates the rate of cross-bridge detachment, thereby enhancing relaxation to mediate diastolic function. Methods and Results—: We compared mouse models expressing phosphorylation-deficient cMyBP-C(S273A/S282A/S302A)–cMyBP-C(t3SA), phosphomimetic cMyBP-C(S273D/S282D/S302D)–cMyBP-C(t3SD), and wild-type-control cMyBP-C(tWT) to elucidate the functional effects of cMyBP-C phosphorylation. Decreased voluntary running distances, increased lung/body weight ratios, and increased brain natriuretic peptide levels in cMyBP-C(t3SA) mice demonstrate that phosphorylation deficiency is associated with signs of HF. Echocardiography (ejection fraction and myocardial relaxation velocity) and pressure/volume measurements (−d P /d t min , pressure decay time constant τ -Glantz, and passive filling stiffness) show that cMyBP-C phosphorylation enhances myocardial relaxation in cMyBP-C(t3SD) mice, whereas deficient cMyBP-C phosphorylation causes diastolic dysfunction with HFpEF in cMyBP-C(t3SA) mice. Simultaneous force and [Ca 2+ ] i measurements on intact papillary muscles show that enhancement of relaxation in cMyBP-C(t3SD) mice and impairment of relaxation in cMyBP-C(t3SA) mice are not because of altered [Ca 2+ ] i handling, implicating that altered cross-bridge detachment rates mediate these changes in relaxation rates. Conclusions—: cMyBP-C phosphorylation enhances relaxation, whereas deficient phosphorylation causes diastolic dysfunction and phenotypes resembling HFpEF. Thus, cMyBP-C is a potential target for treatment of HFpEF.
- 1 April 2015
- Published by Elsevier in Translational Research
- Vol. 165 (4) , 449-463
Pre-eclampsia has an adverse impact on maternal and fetal health
- 1 April 2015
- Published by Elsevier in Translational Research
- Vol. 165 (4) , 449-463
Pre-eclampsia has an adverse impact on maternal and fetal health
- 1 September 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 219 (3) , S40
Tissue Inhibitor of Metalloproteinases-2 (TIMP2) Inhibits Hemorrhagic Shock (HS)-Induced Vascular Hyperpermeability
- 1 September 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 219 (3) , S40
Tissue Inhibitor of Metalloproteinases-2 (TIMP2) Inhibits Hemorrhagic Shock (HS)-Induced Vascular Hyperpermeability
- 1 May 2014
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 49 (5) , 727-732
Intrauterine growth restriction and prematurity influence regulatory T cell development in newborns
- 1 May 2014
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 49 (5) , 727-732
Intrauterine growth restriction and prematurity influence regulatory T cell development in newborns
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4
Effect of gestational age and mode of delivery on CD4+ T cells and regulatory T cells (Treg) in neonatal cord blood
Purpose: Regulatory T cells (Treg), a subset of CD4+ T cells expressing FoxP3 and CD25, comprise 1-3% of CD4+ T cells in adult peripheral blood and have been shown to suppress immune responses. The aim is to determine the effect of gestational age and mode of birth on Tregs in cord blood of human newborns. Methods: Cord blood of 200 newborns was collected between June 2012 and January 2013 and mononuclear cells (CBMCs) were analyzed using four-color flow cytometry. Tregs (CD3+, CD4+, CD25high, FoxP3high) were identified, and FoxP3 mean fluorescence intensity (MFI) measured. Suppressive index (SI) was calculated as MFI of FoxP3/Treg for individual Treg suppressive capacity. Results: CD4+ percentage of CBMCs was 19±9% at 23-32 weeks gestational age (n=14), 12±10% between 33-36 weeks (n=35) and 12±9% at term (n=72) (p=0.03). Tregs remained at 11±5% until completion of gestation, then diminished to 7±5% (p<0.001). SI increased over 10-fold during gestation (55±10635 at 23-32 weeks, 111±11863 at 33-36 weeks, 1679±12963 at term, p=0.7). Mode of delivery did not affect Treg levels (vaginal delivery (n=30): 6±4% vs. caesarean section (n=42): 8±6%; p=0.13). Conclusions: CD4+ T cells in cord blood decrease significantly at mid-third trimester. Tregs are significantly lower in term newborns but had higher suppressive activity. Gestational age and mode of birth effects on Treg suppressive activity may have implications for pre-term infants who cannot suppress an antigen-specific response to newly acquired gut flora or intestinal epithelium, potentially leading to symptoms of necrotizing enterocolitis.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4
Open AccessEffect of gestational age and mode of delivery on CD4+ T cells and regulatory T cells (Treg) in neonatal cord blood
Purpose: Regulatory T cells (Treg), a subset of CD4+ T cells expressing FoxP3 and CD25, comprise 1-3% of CD4+ T cells in adult peripheral blood and have been shown to suppress immune responses. The aim is to determine the effect of gestational age and mode of birth on Tregs in cord blood of human newborns. Methods: Cord blood of 200 newborns was collected between June 2012 and January 2013 and mononuclear cells (CBMCs) were analyzed using four-color flow cytometry. Tregs (CD3+, CD4+, CD25high, FoxP3high) were identified, and FoxP3 mean fluorescence intensity (MFI) measured. Suppressive index (SI) was calculated as MFI of FoxP3/Treg for individual Treg suppressive capacity. Results: CD4+ percentage of CBMCs was 19±9% at 23-32 weeks gestational age (n=14), 12±10% between 33-36 weeks (n=35) and 12±9% at term (n=72) (p=0.03). Tregs remained at 11±5% until completion of gestation, then diminished to 7±5% (p<0.001). SI increased over 10-fold during gestation (55±10635 at 23-32 weeks, 111±11863 at 33-36 weeks, 1679±12963 at term, p=0.7). Mode of delivery did not affect Treg levels (vaginal delivery (n=30): 6±4% vs. caesarean section (n=42): 8±6%; p=0.13). Conclusions: CD4+ T cells in cord blood decrease significantly at mid-third trimester. Tregs are significantly lower in term newborns but had higher suppressive activity. Gestational age and mode of birth effects on Treg suppressive activity may have implications for pre-term infants who cannot suppress an antigen-specific response to newly acquired gut flora or intestinal epithelium, potentially leading to symptoms of necrotizing enterocolitis.
- 1 October 2011
- Published by Elsevier in Experimental Neurology
- Vol. 231 (2) , 247-260
RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury
- 1 October 2011
- Published by Elsevier in Experimental Neurology
- Vol. 231 (2) , 247-260
RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury